Nanotechnology-based drug delivery for central nervous system disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanotechnology-based drug delivery for central nervous system disorders
Authors
Keywords
CNS, Nanoparticles, Molecular targets, Oxidative stress, Nanomedicine
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 143, Issue -, Pages 112117
Publisher
Elsevier BV
Online
2021-09-01
DOI
10.1016/j.biopha.2021.112117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in developing therapeutic strategies for Alzheimer's disease
- (2021) Thuy Trang Nguyen et al. BIOMEDICINE & PHARMACOTHERAPY
- Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease
- (2021) Victoria Monge-Fuentes et al. Scientific Reports
- Preparation, Optimization, and Evaluation of Methoxy Poly(ethylene glycol)-co-Poly(ε-caprolactone) Nanoparticles Loaded by Rivastigmine for Brain Delivery
- (2020) Hamed Mohamadpour et al. ACS Chemical Neuroscience
- Light-induced chiral FexCuySe nanoparticles prevent β-amyloidopathy in vivo
- (2020) Hua Kuang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
- (2020) Yanjie Liu et al. NANO LETTERS
- In Vitro and in Vivo Evaluation of Levodopa Loaded Nanoparticles for Nose to Brain Delivery
- (2020) Sema Arisoy et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
- (2020) Xiangqi Meng et al. Nature Communications
- Cerium Oxide Nanoparticles Rescue α-Synuclein-Induced Toxicity in a Yeast Model of Parkinson’s Disease
- (2020) Roberta Ruotolo et al. Nanomaterials
- Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation
- (2020) Nanxia Zhao et al. Frontiers in Bioengineering and Biotechnology
- Nanomedicine-based immunotherapy for central nervous system disorders
- (2020) Sumaira Hanif et al. ACTA PHARMACOLOGICA SINICA
- Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease
- (2020) Thuy Trang Nguyen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease
- (2020) Subrat K. Bhattamisra et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Amyloidogenic processing of Alzheimer’s disease β-amyloid precursor protein induces cellular iron retention
- (2020) Andrew Tsatsanis et al. MOLECULAR PSYCHIATRY
- Role of Insulin Resistance in the Alzheimer's Disease Progression
- (2020) Thuy Trang Nguyen et al. NEUROCHEMICAL RESEARCH
- Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease
- (2020) Chunhong Gao et al. JOURNAL OF NANOBIOTECHNOLOGY
- Self-assembled polydopamine nanoparticles improve treatment in Parkinson's disease model mice and suppress dopamine-induced dyskinesia
- (2020) Long Binh Vong et al. Acta Biomaterialia
- Targeting nanoparticles to the brain by exploiting the blood–brain barrier impermeability to selectively label the brain endothelium
- (2020) Daniel Gonzalez-Carter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme
- (2020) Ping Sun et al. International Journal of Nanomedicine
- Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in alzheimer’s disease
- (2020) Rehab Ahmed Rifaai et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Recent advancements in liposome-based strategies for effective drug delivery to the brain
- (2020) Parvin Zaman et al. CURRENT MEDICINAL CHEMISTRY
- Nanomaterials for Parkinson disease: Recent progress
- (2020) Esraa Ghazy et al. JOURNAL OF MOLECULAR STRUCTURE
- Alpha-Synuclein—Nanoparticle Interactions: Understanding, Controlling and Exploiting Conformational Plasticity
- (2020) Mariapina D’Onofrio et al. MOLECULES
- Copper oxide nanoparticles promote α-synuclein oligomerization and underlying neurotoxicity as a model of Parkinson's disease
- (2020) Jingjun Lyu et al. JOURNAL OF MOLECULAR LIQUIDS
- Integration of phospholipid-complex nanocarrier assembly with endogenous N-oleoylethanolamine for efficient stroke therapy
- (2019) Xiangrui Yang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Microtubule network as a potential candidate for targeting by gold nanoparticle-assisted photothermal therapy
- (2019) Behafarid Ghalandari et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy
- (2019) Huaqing Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Applications of nanotechnology in drug delivery to the central nervous system
- (2019) Majid Saeedi et al. BIOMEDICINE & PHARMACOTHERAPY
- Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease
- (2019) Lei Zhang et al. BIOMATERIALS
- Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment – Synergistic effect of thrombolysis and antioxidant –
- (2019) Ting Mei et al. BIOMATERIALS
- Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
- (2019) Amanda Cano et al. JOURNAL OF CONTROLLED RELEASE
- Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer's disease-related pathology in 5XFAD mice
- (2019) Seong Gak Jeon et al. Nanomedicine-Nanotechnology Biology and Medicine
- Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer's disease
- (2019) Bernadet L. Klaassens et al. NEUROIMAGE
- Encapsulation of temozolomide in a calixarene nanocapsule improves its stability and enhances its therapeutic efficacy against glioblastoma
- (2019) Alexander Renziehausen et al. MOLECULAR CANCER THERAPEUTICS
- Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
- (2019) Marie-Laure Arotcarena et al. Cells
- Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease
- (2019) Shweta Kishor Sonawane et al. ACS Omega
- Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery
- (2019) Kowthavarapu Venkata Krishna et al. ACS Chemical Neuroscience
- Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection
- (2019) Mengnan Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma
- (2019) Wei Fu et al. ACS Applied Materials & Interfaces
- Vitamin K1 As A Potential Molecule For Reducing Single-Walled Carbon Nanotubes-Stimulated α-Synuclein Structural Changes And Cytotoxicity
- (2019) Amitis Naskhi et al. International Journal of Nanomedicine
- Nanomedicine Against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
- (2019) Pederzoli et al. Pharmaceutics
- Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
- (2019) Jinbing Xie et al. BIOMATERIALS
- Ceria Nanoparticle Systems for Selective Scavenging of Mitochondrial, Intracellular, and Extracellular Reactive Oxygen Species in Parkinson's Disease
- (2018) Hyek Jin Kwon et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nanoparticle Formulation Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel for Chemotherapy Delivery to the Brain
- (2018) Joseph Bteich et al. BIOCONJUGATE CHEMISTRY
- Personalized nanomedicine for CNS diseases
- (2018) Ajeet Kaushik et al. DRUG DISCOVERY TODAY
- Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting
- (2018) Maryam Ghaffari et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity
- (2018) Ruhi Raj et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects
- (2018) Xiuju Yan et al. International Journal of Nanomedicine
- Crossing the blood-brain barrier with nanoparticles
- (2018) Yiqun Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model
- (2018) Dario Carradori et al. Nanomedicine-Nanotechnology Biology and Medicine
- Neuroprotective effect of gold nanoparticles composites in Parkinson's disease model
- (2018) Kaikai Hu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide
- (2018) Ashok Kumar Sharma et al. PHARMACEUTICAL RESEARCH
- Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
- (2018) Fred C. Lam et al. Nature Communications
- Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
- (2018) Elena Sánchez-López et al. JOURNAL OF NANOBIOTECHNOLOGY
- Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting
- (2018) Liuxiang Chu et al. DRUG DELIVERY
- The Role of the Blood Brain Barrier in Neurodegenerative Disorders and their Treatment
- (2018) Alan M. Palmer JOURNAL OF ALZHEIMERS DISEASE
- Is Amyloid-β an Innocent Bystander and Marker in Alzheimer's Disease? Is the Liability of Multivalent Cation Homeostasis and its Influence on Amyloid-β Function the Real Mechanism?
- (2018) Arash ManafiRad et al. JOURNAL OF ALZHEIMERS DISEASE
- Mitochondrial therapeutic interventions in Alzheimer’s disease
- (2018) Vo Van Giau et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease
- (2018) Vinay Sridhar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer’s Disease
- (2018) Bahareh Eftekharzadeh et al. NEURON
- PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor
- (2018) Carlos Fernandes et al. ACS Applied Materials & Interfaces
- Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots
- (2018) Marianna Colasuonno et al. ACS Nano
- A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease
- (2018) Xinlong Huo et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Roadmap and strategy for overcoming infusion reactions to nanomedicines
- (2018) Janos Szebeni et al. Nature Nanotechnology
- Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice
- (2018) Sunena et al. Current Drug Delivery
- Micro- and nanotechnology approaches to improve Parkinson's disease therapy
- (2018) Pablo Vicente Torres-Ortega et al. JOURNAL OF CONTROLLED RELEASE
- Tissue plasminogen activator-based nanothrombolysis for ischemic stroke
- (2017) Shan Liu et al. Expert Opinion on Drug Delivery
- Chitosan nanofilm and electrospun nanofiber for quick drug release in the treatment of Alzheimer’s disease: In vitro and in vivo evaluation
- (2017) Keshireddy AnjiReddy et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Liposomal temozolomide drug delivery using convection enhanced delivery
- (2017) Mirjam M. Nordling-David et al. JOURNAL OF CONTROLLED RELEASE
- Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
- (2017) Eva Bagyinszky et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin
- (2017) Suma Prabhu et al. Nanoscale
- Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease
- (2017) Elisa Conti et al. NEUROCHEMISTRY INTERNATIONAL
- Long Acting Ionically Paired Embonate Based Nanocrystals of Donepezil for the Treatment of Alzheimer’s Disease: a Proof of Concept Study
- (2017) Naresh Mittapelly et al. PHARMACEUTICAL RESEARCH
- Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model
- (2017) Shuiqin Niu et al. Theranostics
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer’s Disease
- (2016) Hyek Jin Kwon et al. ACS Nano
- Gold nanoparticle-capped mesoporous silica-based H 2 O 2 -responsive controlled release system for Alzheimer’s disease treatment
- (2016) Licong Yang et al. Acta Biomaterialia
- Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization
- (2016) Jill M. Steinbach et al. Acta Biomaterialia
- Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain
- (2016) Marianne Petro et al. BIOMATERIALS
- Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors
- (2016) Michiaki Okuda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment
- (2016) Joana A. Loureiro et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management
- (2016) Amira S. Hanafy et al. DRUG DELIVERY
- Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
- (2016) Héloïse Ragelle et al. Expert Opinion on Drug Delivery
- Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat
- (2016) Alireza Partoazar et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration
- (2016) Stephen F. Rodrigues et al. Journal of Biomedical Nanotechnology
- Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases
- (2016) Cláudia Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Highly selective luminescent nanostructures for mitochondrial imaging and targeting
- (2016) E. Fanizza et al. Nanoscale
- Effect of mesenchymal stem cells and galantamine nanoparticles in rat model of Alzheimer's disease
- (2016) Shubham Misra et al. Regenerative Medicine
- Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions
- (2015) Tatsuya Fukuta et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Gold, Silver and Carbon Nanoparticles Grafted on Activated Polymers for Biomedical Applications
- (2015) A. Reznickova et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Gene panels and primers for next generation sequencing studies on neurodegenerative disorders
- (2015) Vo Van Giau et al. Molecular & Cellular Toxicology
- Current approaches to enhance CNS delivery of drugs across the brain barriers
- (2014) Cui-Tao Lu et al. International Journal of Nanomedicine
- Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis
- (2014) Shahriar Absar et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced Doxorubicin Delivery to the Brain Administered Through Glutathione PEGylated Liposomal Doxorubicin (2B3-101) as Compared with Generic Caelyx,®/Doxil®—A Cerebral Open Flow Microperfusion Pilot Study
- (2014) Thomas Birngruber et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The blood-brain barrier: Structure, function and therapeutic approaches to cross it
- (2014) Marta Tajes et al. MOLECULAR MEMBRANE BIOLOGY
- B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
- (2013) Zhongyang Liu et al. BIOCONJUGATE CHEMISTRY
- Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
- (2013) Li-Li Zou et al. Current Neuropharmacology
- Preparation, characterization,in vivobiodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting
- (2013) Shadab Md et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson’s disease
- (2013) Enara Herrán et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Novel L -Lactide-Depsipeptide Polymeric Carrier for Enhanced Brain Uptake of Rivastigmine in Treatment of Alzheimer's Disease
- (2013) Kunal P. Pagar et al. Journal of Biomedical Nanotechnology
- Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: Involvement of BDNF and Akt/GSK-3β signaling pathway
- (2013) Juliana B. Hoppe et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
- (2013) J. Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme
- (2012) Feng-Yi Yang et al. JOURNAL OF CONTROLLED RELEASE
- The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue
- (2011) Mara Canovi et al. BIOMATERIALS
- New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations
- (2011) N. Başaran Mutlu et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model
- (2011) Susan T. Laing et al. THROMBOSIS RESEARCH
- Current approaches to the treatment of Parkinson’s disease
- (2011) Joseph Jankovic Neuropsychiatric Disease and Treatment
- Therapeutic effects of a reducible poly (oligo-d-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury
- (2010) Hyesun Hyun et al. BIOMATERIALS
- Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide
- (2010) Marco Gobbi et al. BIOMATERIALS
- Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
- (2010) Spyridon Mourtas et al. BIOMATERIALS
- Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology
- (2010) G. Mittal et al. JOURNAL OF CONTROLLED RELEASE
- Alzheimer's Disease: From Pathology to Therapeutic Approaches
- (2009) Roland Jakob-Roetne et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain
- (2009) Zhao H. Wang et al. BIOMATERIALS
- Nanomedicine and Society
- (2009) M Ferrari et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Silica-Based Nanoparticle Uptake and Cellular Response by Primary Microglia
- (2009) Judy Choi et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain
- (2009) Samantha Pillay et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanoparticles for direct nose-to-brain delivery of drugs
- (2009) Alpesh Mistry et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
- (2009) A. B. Madhankumar et al. MOLECULAR CANCER THERAPEUTICS
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles
- (2008) B WILSON et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Environmental challenges for nanomedicine
- (2008) Anders Baun et al. Nanomedicine
- Seven challenges for nanomedicine
- (2008) Wendy R. Sanhai et al. Nature Nanotechnology
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started